In the case of pre-menopausal females, tapering the anabolic-androgenic steroids (AAS) would be the best treatment.
Anabolic steroid administration, like males, causes the HPGA to shutdown. However, stopping the AAS will produce menopausal like symptoms, therefore tapering until menses returns is best. The labs follicle stimulating hormone (FSH), luteneizing hormone (LH), progesterone (P) and estradiol (E2) will be the best indicator. They will show if the HPGA is affected adversely. In marked contrast to a man, the period typically returns within 1-2 months and will occur while tapering.
I would NOT suggest “selective estrogen receptor modulators” (SERMs) or aromatase inhibitors (AIs) for a woman! NEVER! It is the equivalency of forcing them into menopausal symptoms. The HPGA/HPTA are very different. In fact, SERM/AI (such as Nolvadex and Arimidex) are used in Breast Cancer, which includes a significant number of adverse effects. Decreasing E2 in a man is far different from doing the same in a female. E2 and P are the main female hormones. Just imagine how a man feels that receives Androgen Deprivation Therapy (ADT) for Prostate Cancer.
